Celldex Therapeutics Announces Pricing of Upsized $250 Million Public Offering of Common Stock

Retrieved on: 2021-07-14 00:22:30

Tags for this article:

Finance

Initial public offering

U.S. Securities and Exchange Commission

Prospectus

Forward-looking statement

SVB Leerink

Shelf registration

Public offering

Celldex Therapeutics Inc.

Click the tags to see associated articles and topics

Celldex Therapeutics Announces Pricing of Upsized $250 Million Public Offering of Common Stock. View article details on hiswai:

Excerpt

(“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the pricing of an underwritten public offering of 5,952,381 shares of its common stock at ...

Article found on: finance.yahoo.com

View Original Article